For Healthcare Professionals Only
Pemphigus foliaceus is a relatively benign autoimmune bullous disease associated with the deposition of intercellular antibodies directed against desmoglien 1. The therapeutic approach differs significantly from that for pemphigus vulgaris; therapy is adjusted on the basis of clinical response rather than immunopathologic data. The goal is to control lesion formation, although an occasional blister should be tolerated, as chronic effects of therapy may be more dangerous than the disease. Pemphigus erythematosus may be treated like pemphigus foliaceus.
CONTENT PROVIDED BY:
Disclaimer: The material above has been prepared by Derm101.com. It has not been reviewed by the DermQuest Editorial Board for its accuracy or reliability. Reference to any products, service, or other information does not constitute or imply endorsement, sponsorship, or recommendation by members of the Editorial Board.